KDP vs LXRX · P/E 23, rev $11.29B vs rev $21.8M
Keurig Dr Pepper Inc (KDP) versus Lexicon Pharmaceuticals Inc (LXRX) — a side-by-side from cached financials, not a winner call.
Keurig Dr Pepper Inc (KDP) is a beverages - non-alcoholic company listed on NASDAQ.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Latest reported KDP revenue for 2026-06-30 was $11.29B. Net income was $412.0M. KDP currently screens at market cap $42.03B and trailing P/E 22.9.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
KDP currently screens at market cap $42.03B and trailing P/E 22.9. LXRX currently screens at market cap $327.2M.
Not investment advice. Open the KDP and LXRX stock pages for the full models.
Not investment advice.